V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240015330 | 240012547 | 1.56 | null | Disease modification (D) | 2016-11-01 | 2016-11-07 | Capecitabine 35days + RT | 2 | N | 240035507 | CARBOPLATIN + DOCETAXEL |
| 240015331 | 240012548 | 1.6 | 58 | Not known (9) | 2017-10-06 | 2017-11-23 | Topotecan (intravenous) | N | N | 240035509 | ETOPOSIDE |
| 240015332 | 240008506 | 1.65 | 70 | Palliative (P) | 2013-07-26 | 2013-08-03 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 240035525 | CISPLATIN + FLUOROURACIL |
| 240015333 | 240008511 | null | 78.6 | Palliative (P) | null | 2016-08-06 | DA-EPOCH-R | 02 | N | 240035538 | FEC |
| 240015334 | 240015401 | 1.65 | 81.9 | Curative (C) | 2018-12-05 | 2018-12-06 | Mitoxantrone | 2 | N | 240035550 | CARBOPLATIN + VINORELBINE |
| 240015335 | 240008512 | 1.66 | 86 | Curative (C) | 2015-09-27 | 2015-09-27 | Topotecan (intravenous) | 2 | N | 240035551 | GEMCITABINE + OXALIPLATIN + RITUXIMAB |
| 240015336 | 240008517 | 1.71 | null | Palliative (P) | 2014-03-16 | 2014-03-16 | R CODOX M | 02 | N | 240035554 | RUXOLITINIB |
| 240015337 | 240008521 | 1.5 | 60.9 | Disease modification (D) | 2015-04-21 | 2015-04-22 | Liposomal Doxorubicin (Caelyx) | 2 | N | 240035582 | PEMBROLIZUMAB |
| 240015338 | 240008525 | 1.76 | 78.2 | Curative (C) | 2016-09-07 | 2016-09-07 | R-PMitCEBOM | 2 | N | 240035590 | GEMCITABINE + OXALIPLATIN + RITUXIMAB |
| 240015339 | 240008529 | 0 | 42.2 | Palliative (P) | 2015-06-07 | 2015-06-07 | DA-EPOCH-R | N | N | 240000098 | ICE |
| 240015340 | 240008530 | 1.75 | 70.8 | Curative (C) | 2015-09-14 | 2015-11-30 | CAPECITABINE + GEMCITABINE | N | null | 240000290 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 240015341 | 240008535 | 1.6 | 64.5 | Palliative (P) | 2016-06-13 | 2016-06-19 | CISPLATIN + FLUOROURACIL + RT | N | N | 240000572 | CARBOPLATIN + LIPOSOMAL DOX |
| 240015342 | 240012562 | null | 65.3 | Curative (C) | 2019-01-04 | 2019-01-04 | Cytarabine High Dose | 02 | N | 240000791 | CARMUSTINE + CYTARABINE + ETOPOSIDE |
| 240015343 | 240008541 | 1.57 | 70.4 | Disease modification (D) | 2017-12-02 | 2017-12-02 | FLAG | 2 | N | 240000855 | AML17 TRIAL |
| 240015344 | 240014460 | 1.67 | 52.1 | Curative (C) | 2014-12-03 | 2015-01-01 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 240001110 | MELPHALAN |
| 240015345 | 240008545 | 1.51 | 48.7 | null | null | 2016-05-25 | CYTARABINE + METHOTREXATE + RITUXIMAB | N | N | 240001214 | TOPOTECAN |
| 240015346 | 240008547 | 1.54 | 113 | Curative (C) | 2014-12-30 | 2014-12-31 | Vinorelbine (oral) | Y | N | 240001263 | CAPECITABINE + GEMCITABINE |
| 240015347 | 240008548 | 1.65 | 59.7 | null | 2015-03-30 | 2015-05-27 | Nilotinib | N | N | 240001374 | VEDEX |
| 240015348 | 240008552 | 1.74 | 57 | Disease modification (D) | 2017-07-18 | 2017-07-18 | Cytarabine High Dose | 02 | N | 240001512 | OXALIPLATIN + MDG |
| 240015349 | 240008555 | 1.53 | 51.8 | Curative (C) | 2016-12-08 | 2017-01-01 | Mitoxantrone | N | N | 240001549 | VINCRISTINE |
| 240015350 | 240008563 | null | 81 | Palliative (P) | 2016-05-05 | 2016-05-05 | PEMBROLIZUMAB | N | N | 240002318 | CVD |
| 240015351 | 240008568 | null | 75.6 | Curative (C) | 2013-12-19 | 2014-02-14 | Oxaliplatin + Modified de Gramont | N | N | 240002469 | IRINOTECAN + MDG |
| 240015352 | 240008570 | 1.63 | null | Curative (C) | 2015-01-14 | 2015-01-18 | TOPOTECAN | N | N | 240002486 | CISPLATIN + PACLITAXEL |
| 240015353 | 240008577 | 1.7 | 85 | Curative (C) | 2016-04-23 | 2016-05-07 | MATRIX (lymphoma) | N | N | 240002854 | CHOEP |
| 240015354 | 240012587 | 1.66 | 65 | Curative (C) | 2016-09-29 | 2016-11-22 | CISPLATIN + FLUOROURACIL | N | null | 240003250 | IRINOTECAN + MDG |
| 240015355 | 240012589 | 1.7 | 90 | Disease modification (D) | 2014-02-24 | 2014-02-24 | CAV | 02 | N | 240003545 | LIPOSOMAL DOXORUBICIN |
| 240015356 | 240008588 | 1.6 | 64.7 | Palliative (P) | 2016-11-01 | 2016-11-01 | Cytarabine HD + Methotrexate HD | 2 | N | 240003818 | AML17 TRIAL |
| 240015357 | 240008591 | 1.6 | 67.6 | Curative (C) | 2017-10-16 | 2017-10-23 | Escalated BEACOPP | 2 | N | 240004276 | ICE-R |
| 240015358 | 240008594 | 1.69 | 57.8 | Adjuvant (A) | 2018-08-02 | 2018-08-03 | Capecitabine + Oxaliplatin 14day | N | N | 240004510 | UKALL60+ |
| 240015359 | 240012595 | 1.71 | 51 | Palliative (P) | null | 2018-01-07 | PIXANTRONE | N | N | 240004667 | TOPOTECAN |
| 240015360 | 240012597 | 1.63 | null | Curative (C) | 2016-06-18 | 2016-06-18 | Capecitabine + Oxaliplatin 21day | 02 | N | 240004839 | FAB LMB |
| 240015361 | 240008600 | 1.78 | 70.6 | Not known (9) | 2014-01-02 | 2014-01-02 | Enzalutamide | N | Y | 240005033 | CYCLOPHOSPHAMIDE + VINBLASTINE |
| 240015362 | 240008604 | 0 | 57.8 | Curative (C) | 2014-07-24 | 2014-07-24 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 2 | N | 240005082 | DOCETAXEL |
| 240015363 | 240008608 | null | 82 | Palliative (P) | 2018-02-15 | 2018-02-16 | MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | N | N | 240005364 | IVE |
| 240015364 | 240008609 | null | 57 | Palliative (P) | 2016-01-18 | 2016-01-29 | DHAP - R | 02 | N | 240005562 | PIXANTRONE |
| 240015365 | 240008624 | 1.64 | 89 | Palliative (P) | 2017-10-07 | 2017-10-11 | Vinorelbine (oral) | 02 | N | 240006577 | ATG + BUSULFAN + FLUDARABINE |
| 240015366 | 240008635 | 1.7 | 24.7 | Palliative (P) | 2017-02-05 | 2017-02-15 | Y-90 | N | null | 240007399 | NHL 2003 |
| 240015367 | 240012614 | 1.53 | null | Palliative (P) | 2019-08-17 | 2019-09-20 | BENDAMUSTINE + BORTEZOMIB | Y | null | 240007531 | ATG + BUSULFAN + FLUDARABINE + THIOTEPA |
| 240015368 | 240008641 | 1.74 | 96 | Disease modification (D) | 2016-07-04 | 2016-07-04 | Cytarabine HD + Methotrexate HD | N | null | 240007767 | GALLIUM TRIAL |
| 240015369 | 240008643 | null | 81.7 | Curative (C) | 2017-04-18 | 2017-12-08 | NAB PACLITAXEL | N | N | 240007918 | VIOLA TRIAL |
| 240015370 | 240016334 | 1.69 | 85.4 | Palliative (P) | 2019-09-15 | 2019-09-20 | BORTEZOMIB + RITUXIMAB | N | N | 240007996 | PIXANTRONE |
| 240015371 | 240008645 | 1.59 | 44.8 | null | 2019-03-26 | 2019-03-27 | Liposomal Doxorubicin (Caelyx) | N | N | 240008056 | DABRAFENIB + TRAMETINIB |
| 240015372 | 240008649 | 1.61 | 80.9 | Curative (C) | 2018-07-12 | 2018-07-12 | Docetaxel + Gemcitabine (prior RT) | N | N | 240008265 | AML18 TRIAL |
| 240015373 | 240008650 | 1.58 | 50.9 | Palliative (P) | 2016-08-10 | 2016-08-10 | VAC | 02 | N | 240008306 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 240015374 | 240008658 | null | 135 | Palliative (P) | 2016-04-25 | 2016-05-06 | BEAM + FLUDARABINE | null | null | 240008463 | DARATUMUMAB |
| 240015375 | 240008663 | 1.54 | 48.7 | Palliative (P) | 2014-05-14 | 2014-11-06 | VEDex | Y | N | 240008658 | BORTEZOMIB + RITUXIMAB |
| 240015376 | 240008667 | 1.74 | 80 | Curative (C) | 2014-08-16 | 2014-08-16 | MYELOMA XI TRIAL | 02 | N | 240008851 | R CODOX-M/ R IVAC |
| 240015377 | 240012629 | null | null | Curative (C) | 2015-11-06 | 2015-11-07 | CODOX M | N | null | 240009295 | BOSUTINIB |
| 240015378 | 240008677 | 1.81 | 50 | Palliative (P) | 2017-02-19 | 2017-07-05 | REMODLB TRIAL | N | N | 240009614 | CRIZOTINIB |
| 240015379 | 240008680 | null | 68.7 | Disease modification (D) | 2017-05-04 | 2017-05-06 | AML 19 TRIAL | N | N | 240009661 | CYTARABINE + METHOTREXATE + RITUXIMAB |